Capital Investment Advisory Services’s Better Therapeutics, Inc. Common Stock BTTX Stock Holding History

Capital Investment Advisory Services’s Portfolio BTTX Stock Details BTTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-71,000	Closed	-$994	–	1004
2024 Q1	$994	Hold	71,000	–	–	﹤0.01%	933
2023 Q4	$13.8K	Buy	71,000 +30,000	+73%	+$6.52K	﹤0.01%	805
2023 Q3	$15K	Buy	+41,000	New	+$27.7K	﹤0.01%	753

Other funds holding BTTX

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Capital Investment Advisory Services's BTTX Position: Q2 2024 in Review

Capital Investment Advisory Services sold out of Better Therapeutics, Inc. Common Stock (BTTX) in Q2 2024, closing a stake of 71,000 shares — an estimated $994 sold.

Capital Investment Advisory Services first reported a position in BTTX in Q3 2023 and held it in 3 quarters. The position peaked at $15K in Q3 2023. 1 fund tracked by Wall St. Rank holds BTTX as of Q2 2024.

Capital Investment Advisory Services reported no remaining Better Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Capital Investment Advisory Services sold 71,000 Better Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $994.
Capital Investment Advisory Services first reported a position in Better Therapeutics, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
Capital Investment Advisory Services's Better Therapeutics, Inc. Common Stock position peaked at $15K in Q3 2023.
1 fund tracked by Wall St. Rank held Better Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Capital Investment Advisory Services's 13F filing for Q2 2024, filed 14 Aug 2024.